Skip to main content
. 2014 Jul 17;24:14023. doi: 10.1038/npjpcrm.2014.23

Figure 1.

Figure 1

Combined approaches for the management of control in asthma.2,5,10–16 FLAP, 5-lipoxygenase-activating protein; ICS, inhaled corticosteroids; IL, interleukin; LABA, long-acting β2-agonist; PDE4, phosphodiesterase-4; SABA, short-acting β2-agonist.